Rhythm Pharmaceuticals buy Morgan Stanley
Start price
19.12.23
/
50%
€42.40
Target price
19.12.24
€50.16
Performance (%)
30.90%
End price
20.12.24
€55.50
Summary
This prediction ended on 20.12.24 with a price of €55.50. The BUY prediction by Morgan_Stanley for Rhythm Pharmaceuticals saw massive gains of 30.90%. Morgan_Stanley has a follow-up prediction for Rhythm Pharmaceuticals where he still thinks Rhythm Pharmaceuticals is a Buy. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Rhythm Pharmaceuticals | -5.202% | -5.202% | 88.052% |
| iShares Core DAX® | 0.245% | -1.751% | 27.129% |
| iShares Nasdaq 100 | 1.694% | 0.633% | 17.351% |
| iShares Nikkei 225® | 3.771% | 2.653% | 9.863% |
| iShares S&P 500 | 1.432% | 1.748% | 12.087% |
Comments by Morgan_Stanley for this prediction
In the thread Rhythm Pharmaceuticals diskutieren
Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) was upgraded by analysts at Morgan Stanley from an "equal weight" rating to an "overweight" rating. They now have a $55.00 price target on the stock, up previously from $29.00.
Ratings data for RYTM provided by MarketBeat
In the thread Trading Rhythm Pharmaceuticals
Die von Morgan_Stanley gewählte maximale Laufzeit wurde überschritten
Current prediction by Morgan_Stanley for Rhythm Pharmaceuticals
Rhythm Pharmaceuticals
Start price
Target price
Perf. (%)
€46.80
07.03.25
07.03.25
€66.38
07.03.26
07.03.26
75.21%
12.09.25
12.09.25
Stopped prediction by Morgan_Stanley for Rhythm Pharmaceuticals
Rhythm Pharmaceuticals
Start price
Target price
Perf. (%)
€74.50
11.07.25
11.07.25
€81.37
11.07.26
11.07.26
10.07%
12.09.25
12.09.25